Skip to main content
You're viewing the free public version. Create a free account for full research and member tools. Join free
Research Abstract Human: Case Report

Although only 1% of vaccine adverse events are reported to VAERS, the system received 29,747 reports after Hib vaccines. 5179 were serious and 896 were reported deaths, with 51% of the deaths being attributed to Sudden Infant Death Syndrome.

Adverse events following Haemophilus influenzae type b vaccines in the Vaccine Adverse Event Reporting System, 1990-2013.

0:00 / 0:00
0:00 / 0:00

Sign in to access this feature

Create a free account or sign in to use AI summaries, listen to articles, download PDFs, and save to your library.

169 views
Share:

Abstract

OBJECTIVE: To characterize adverse events (AEs) after Haemophilus influenzae type b (Hib) vaccines reported to the US Vaccine Adverse Event Reporting System (VAERS), a spontaneous reporting surveillance system. STUDY DESIGN: We searched VAERS for US reports after Hib vaccines among reports received from January 1, 1990, to December 1, 2013. We reviewed a random sample of reports and accompanying medical records for reports classified as serious. All reports of death were reviewed. Physicians assigned a primary clinical category to each reviewed report. We used empirical Bayesian data mining to identify AEs that were disproportionally reported after Hib vaccines. RESULTS: VAERS received 29,747 reports after Hib vaccines; 5179 (17%) were serious, including 896 reports of deaths. Median age was 6 months (range 0-1022 months). Sudden infant death syndrome was the stated cause of death in 384 (51%) of 749 death reports with autopsy/death certificate records. The most common nondeath serious AE categories were neurologic (80; 37%), other noninfectious (46; 22%) (comprising mainly constitutional signs and symptoms); and gastrointestinal (39; 18%) conditions. No new safety concerns were identified after clinical review of reports of AEs that exceeded the data mining statistical threshold. CONCLUSION: Review of VAERS reports did not identify any new or unexpected safety concerns for Hib vaccines.

Affiliation

Pedro L Moro

External References

PubMed ID:
25598306

Comments

Sign in or create a free account to join the conversation.

Sign in to comment

Be the first to comment.

More Research Abstracts

View All Abstracts
Animal Study

Aluminum--based adjuvants induce persistent, sterile, subcutaneous granulomas with macrophage-driven translocation of aluminum to regional lymph nodes in sheep.

Jan 1, 2019 Javier Asín, Jéssica Molín, Marta Pérez, Pedro Pinczowski, Marina Gimeno, Nuria Navascués, Ana Muniesa, Ignacio de Blas, Delia Lacasta, Antonio Fernández, Lorena de Pablo, Matthew Mold, Christopher Exley, Damián de Andrés, Ramsés Reina, Lluís Luján

Vet Pathol

Trusted By Professionals and Teams:

The National Health Federation
Stand For Health Freedom
Global Healing Institute
Global Wellness Forum
MAHA Action
Myers Detox
Natural News
Mercola.com

Unlock Evidence-Based Health Research

Join 500,000+ members accessing 10,000+ natural health topics.

Subscribe to our informative Newsletter & Receive

Cancer Fighting Foods Ebook

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of GreenMedInfo or its staff.